These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Future prospects for use of fibrinolysis inhibitors. Verstraete M J Clin Pathol Suppl (R Coll Pathol); 1980; 14():77-80. PubMed ID: 7000851 [No Abstract] [Full Text] [Related]
4. [Antifibrinolytic therapy]. Levi M; ten Cate JW Ned Tijdschr Geneeskd; 1995 Mar; 139(12):613-7. PubMed ID: 7700404 [No Abstract] [Full Text] [Related]
5. [The antifibrinolytic therapy of gynecologic hemorrhages]. Koutský J; Padovec J; Jirásek JE; Rybák M; Hladovec J; Mansfeld V Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):151-65. PubMed ID: 4174653 [No Abstract] [Full Text] [Related]
6. Fibrinolysis and its control. Andersson L S Afr Med J; 1972 Feb; 46(8):182-5. PubMed ID: 4260535 [No Abstract] [Full Text] [Related]
7. [Use of trasylol as an inhibitor of proteases of the fibrinolysis system during extracorporeal circulation]. Masiak M; Bross W Folia Med Cracov; 1980; 22(3-4):455-61. PubMed ID: 6169610 [No Abstract] [Full Text] [Related]
9. [Fibrinolysis. Its resurgence during surgery of portal hypertension]. Guilmet C; Levy E; Vergoz D Nouv Presse Med; 1972 Sep; 1(31):2023-4. PubMed ID: 5086764 [No Abstract] [Full Text] [Related]
10. [Natural inhibitors of fibrinolysis and their physiological importance]. Pastorova VE Usp Fiziol Nauk; 1974; 5(4):80-95. PubMed ID: 4279526 [No Abstract] [Full Text] [Related]
11. Amicar and hyperfibrinolysis. Med Lett Drugs Ther; 1967 Jan; 9(3):10-1. PubMed ID: 6067964 [No Abstract] [Full Text] [Related]
12. Comparative studies of the effect of fibrinolytic inhibitors (synthetic and naturally occurring substances) on coagulation and fibrinolytic systems in vitro and in vivo, and their clinical applications. Matsuoka M; Sakuragawa N; Yoneyama Y Acta Med Biol (Niigata); 1969 Mar; 16(3):105-20. PubMed ID: 4239124 [No Abstract] [Full Text] [Related]
13. [Clinical biochemical justification for the use of fibrinolysis inhibitors in the therapy of hemorrhages in ENT diseases]. Veremeenko KN; Gerasimenko NG; Pogorelova LM Zh Ushn Nos Gorl Bolezn; 1972; (3):56-61. PubMed ID: 4680879 [No Abstract] [Full Text] [Related]
14. [Fibrinolytic hemorrhages in childhood and their therapy with PAMBA]. Hoffmann W; Mey U Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 87(1):88-93. PubMed ID: 4173887 [No Abstract] [Full Text] [Related]
15. A bleeding tongue - acute presentation of fibrinolysis. Hodson A; Hunt BJ Int J Lab Hematol; 2007 Oct; 29(5):393-4. PubMed ID: 17824923 [No Abstract] [Full Text] [Related]
16. [Fibrinolytic hemorrhage and antifibrinolytic preparations]. Panchenko M Klin Med (Mosk); 1969 Mar; 47(3):11-7. PubMed ID: 5406805 [No Abstract] [Full Text] [Related]
17. [Principles and limitations in the use of protease inhibitors as antifibrinolytic agents]. Markwardt F Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):109-22. PubMed ID: 4174648 [No Abstract] [Full Text] [Related]
18. [Clinical surgery and fibrinolysis]. Murakami F; Kadota H Saishin Igaku; 1966 Feb; 21(2):284-91. PubMed ID: 5966315 [No Abstract] [Full Text] [Related]
19. Fibrinolysis Inhibitors: Potential Drugs for the Treatment and Prevention of Bleeding. Steinmetzer T; Pilgram O; Wenzel BM; Wiedemeyer SJA J Med Chem; 2020 Feb; 63(4):1445-1472. PubMed ID: 31658420 [TBL] [Abstract][Full Text] [Related]
20. [Proof of the antifibrinolytic action of the protease inhibitor Contrykal in vivo]. Klöcking HP Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):136-41. PubMed ID: 4174651 [No Abstract] [Full Text] [Related] [Next] [New Search]